Objective To explore the effect of eriodictyol on proliferation, oxidative stress response and TGF⁃β1/Smad signaling pathway activation of human skin fibroblasts (HSF) induced by transforming growth factor β1 (TGF⁃β1). Methods HSF was assigned to control group, model group, eriodictyol low⁃dose group, eriodictyol medium⁃dose group, eriodictyol high⁃dose group, or SB⁃431542 group. The control group did not received any treatment, whereas the model group received intervention for 24 hours with 5 ng/mL TGF⁃β1, and the eriodictyol low⁃, medium, and high⁃dose groups received intervention for 24 hours with 40 μmol/L, 80 μmol/L, and 160 μmol/L eriodictyol and 5.0 ng/mL TGF⁃β1 simultaneously, respectively; in addition, the SB⁃431542 group received intervention for 24 hours with 10 μmol/L SB⁃431542 and 5.0 ng/mL TGF⁃β1 simultaneously. The HSF cell activity, α⁃smooth muscle actin (α⁃SMA) protein expression, reactive oxygen species (ROS) content, superoxide dismutase (SOD) activity, and mRNA expressions of TGF⁃β1, α⁃SMA, collagen type Ⅰ (ColⅠ ), collagen type Ⅲ (Col Ⅲ ), matrix metalloproteinase 2 (MMP2), as well as TGF⁃β1 protein expression were detected in various groups. The protein expressions of Smad2, Smad3, phosphorylated Smad2 (p⁃Smad2), and phosphorylated Smad3 (p⁃Smad3) of HSF were detected in the control group, the model group, and the eriodictyol medium⁃dose group. Results Compared with the control group, the model group exhibited increased HSF cell activity and elevated α⁃SMA protein expression, increased ROS content while decreased SOD activity, up⁃regulated mRNA expressions of TGF⁃β1, α⁃SMA,ColⅠ , Col Ⅲ , and MMP2, and up⁃regulated protein expressions of TGF⁃β1, Smad2, Smad3, p⁃Smad2, and p⁃Smad3 (P<0.05). Compared with the model group, the eriodictyol various⁃dose groups and the SB⁃431542 group yielded decreased HSF cell activity, ROS content, while increased SOD activity, and down⁃regulated mRNA expressions of α⁃SMA, ColⅠ , Col Ⅲ , and MMP2, as well as down⁃regulated protein expression of TGF⁃β1; in addition, eriodictyol medium⁃ and high⁃dose groups and the SB⁃431542 group depicted decreased protein expression of α⁃SMA in HSF cell, and the eriodictyol medium⁃dose group and the SB⁃431542 group interpreted down⁃regulated protein expressions of Smad2, Smad3, p⁃Smad2, and p⁃Smad3 (P<0.05). The eriodictyol low⁃, medium⁃, and high⁃dose groups presented as decreased HSF cell activity, α⁃SMA protein expression, and ROS content successively, and increased SOD activity successively, as well as decreased mRNA expressions of α⁃SMA, ColⅠ , Col Ⅲ successively (P<0.05). Conclusion Eriodictyol may inhibit fibrosis of HSF cell induced by TGF⁃β1 in a dose⁃dependent manner by inhibiting oxidative stress response and the activation of TGF⁃β1/Smad pathway.